Raltegravir: no significant decrease in free concentration during pregnancy
By ANRS The ANRS RalFE study coordinated by Dr Jade Ghosn (hôpital Hôtel-Dieu, APHP) and funded by the ANRS demonstrated that raltegravir free concentrations did not significantly decrease during the third trimester of pregnancy in HIVinfected women. These results were presented this Thursday, 26 July at the 22nd international conference on HIV/AIDS (AIDS 2018), being…